![]() |
|
September 1, 2008 | |
MESSAGE FROM THE DIRECTOR ON STEPHANIE TUBBS JONESAs I sit down to write, the hymns from the August 30 memorial service for Stephanie Tubbs Jones are still ringing in my ears. I just want to add my reflections to members of the Cancer Center and the Stem Cell Center. Stephanie was a wonderful supporter of us all, Cleveland, CWRU, our Comprehensive Cancer Center and its affiliates the Ireland Cancer Center and the Taussig Cancer Institute, and our Stem Cell Center. When I visited her on the Hill, she poured out enthusiasm for her support for NCI funding. In 2006, she offered her support during our competitive Cancer Center Core Grant renewal process and offered to "make that call" if needed. She helped us secure federal funding for the National Center for Regenerative Medicine in 2005, 2006, and 2007. In 2004, Paul DiCorleto and I talked on stem cell research when she chaired the Democratic Party Platform Committee hearing in Cleveland. When I last saw Stephanie in late June, I was leaving the National Airport as she was arriving. After her characteristic bear hug, she asked about our research, our funding, how the hospitals were doing "together," and promised her ongoing support for the NIH and our institutions. We really will miss her support and her passion for Cleveland. Stan Gerson, Director, Case CCC MARK YOUR CALENDARS– Spotlight in Breast Cancer Research Seminar SeriesThe Case Comprehensive Cancer Center is pleased to present the Spotlight in Breast Cancer Research Seminar Series. The goal of this series is to bring 3-4 outstanding breast cancer researchers per year to the Cancer Center for seminars. We will start the series with a talk by Kornelia Polyak, MD, PhD from the Dana Farber Cancer Center. Dr. Polyak is a leader in genomics of breast cancer progression as well as tumor/stromal interactions. In 2008 alone she co-authored papers in Cell, Cancer Cell, Nature Genetics, and The New England Journal of Medicine, as well as others. Her talk is scheduled for Tuesday, September 2 in the Department of Pharmacology's conference room (W331) at noon. We hope to see you there. Another speaker in this series will be Max Wicha, an expert in breast cancer stem cells, who will be here in November. Please contact Ruth Keri if you have suggestions for additional speakers and formats for their visits, and we will work to invite them for the series. This seminar series is just one way we are working to more fully integrate the diverse group of breast cancer/development researchers in the Case Comprehensive Cancer Center. We are also planning a mini-retreat to introduce the different types of research that is being performed here in breast and to facilitate networking between investigators. More information will follow on the date and structure of that event, and we hope you will attend and provide suggestions for addressing your individual needs. You may also be interested to know that Mina Bissell will be giving a talk for the Greenfield Family Lecture in Pharmacology on October 30. Please click here for details. FUNDING OPPORTUNITY– Canary Foundation/ACS Postdoctoral Fellowship in the Early Detection of Cancer for 2009The Canary Foundation has partnered with the American Cancer Society (ACS) to create a postdoctoral fellowship program focused on studies towards development of strategies for early detection of cancer. Research should be directed at new approaches to improve clinical methods for the detection of primary tumors and/or metastases. The projects that will be funded are expected to have a direct impact on the early detection of cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection. Application Deadline: October 15 For details, please click here. PATRICK MA AWARDED TRAVEL GRANTCongratulations to Cancer Center Member Patrick Ma, MD, who was recently awarded a travel grant to attend the Chicago Multidisciplinary Symposium in Thoracic Oncology. The grant was awarded based on Dr. Ma's abstract, "Dual MET-EGFR Inhibition for Erlotinib-Resistant Lung Cancer". The Symposium is co-sponsored by ASTRO, ASCO, IASLC, and the University of Chicago. STAND UP TO CANCER – Call for IdeasAACR invites members of the cancer community to contribute to a groundbreaking effort to accelerate progress against cancer and directly impact patient care. AACR is managing the blue ribbon scientific review of this innovative research program and will assure its integrity. The main objective is to identify and fund "SU2C Dream Team" translational research projects. The number of Dream Teams to be formed will depend upon the total amount of funds raised through SU2C. Based on the scope of each Dream Team project, total support for each Team may reach up to $20 million for 3 years. The AACR is asking you to join this collaborative effort and contribute ideas to help shape the groundbreaking SU2C Dream Team translational research model. In issuing this call, AACR is not accepting research proposal for grant funding. Rather, they are inviting ideas for SU2C Dream Team translational research projects. For information, please click here. On Friday, September 5 from 8:00 pm - 9:00 pm, ABC, CBS, and NBC will donate one hour of prime time for a simulcast, nationally televised fundraising event, uniting the nation as we "Stand Up To Cancer". As an official partner in this new and exciting initiative for cancer research, all funds raised through the event will be channeled through AACR. Note from Dr. Gerson: MARK YOUR CALENDARS & CALL FOR ABSTRACTS– ECOG Young Investigator's SymposiumNovember 16 The purpose of this annual symposium is to engage promising young clinical investigators in cooperative group clinical research. Individuals who meet the criteria are invited to submit an abstract for presentation at the fall ECOG meeting, which will take place November 14-16 in Fort Lauderdale, Florida. The symposium will tentatively take place between 8:30-11:00 am on November 16. Abstracts should be emailed or faxed no later than October 10. For details, please click here. |
EVENTS**All events are open to anyone interested in attending September 1Happy Labor Day! September 2Pharmacology and Case CCC Special Seminar September 3Grand Rounds September 4Taussig Cancer Institute Core Curriculum Series Practice-Based Research Network Seminar September 5Hematology/Oncology Fellows Seminar Taussig Cancer Institute Grand Rounds more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMS**For more information on these symposiums, please contact Christine Rhoads. Family-Centered Care Head and Neck Conference ONCOLOGY CONGRESSSeptember 25-28 The Oncology Congress engages you in productive peer-to-peer discussions about cancer prevention, diagnosis, and treatment options, giving you the practical knowledge, tools, and insight needed to improve care and quality of life for your patients today. The Case CCC has partnered with the Oncology Congress to offer a discounted registration rate for Case CCC members: $395 for physicians and $195 for nurses and physician assistants. To register, please click here, and use priority code COE8. MARK YOUR CALENDARS– NanoMedicine Summit 2008September 25-26 The 2008 Cleveland NanoMedicine Summit, is the anchor event for Nano Week in Cleveland (in its fifth year) and will be co-hosted by NorTech's Nano-Network, the Cleveland Clinic Foundation and Case Western Reserve University. This conference has been incredibly successful in the past (as evidenced by national media attention and feedback from attendees) by bringing together scientists, clinicians, business professionals, investors and others to learn, discuss and interact under the umbrella of nanomedicine. The 2008 Summit will focus on the use of nanoparticles for diagnostics and therapeutics. Session highlights include: Many Cancer Center members are involved in this Summit. Drs. James Basilion, Vinod Labhasetwar, and Maciej Zborowski are on the Organizing Committee, and the following members are scheduled to speak: Drs. Stanton Gerson, Clemens Burda, Agata Exner, Vinod Labhasetwar, Horst von Recum, Pam Davis, Mark Cooper, and Thomas Budd. For more information, please click here. |
MARK YOUR CALENDARS– AACR Centennial SymposiumOctober 27-28 The AACR Centennial Symposium: The Future of Cancer Research: Science and Patient Impact will focus on the latest and future advances in cancer research, technologies, and techniques. This forward-looking centennial symposium will also be honoring the long history that the AACR has had with the Roswell Park Cancer Institute. Advance Registration Deadline: September 15 For details, please click here. MARK YOUR CALENDARS– 61st Annual Symposium on Cancer Research: Systems Biology of CancerOctober 30-November 1 The University of Texas MD Anderson Cancer Center is pleased to host the 61st Annual Symposium on Cancer Research: Systems Biology of Cancer. This symposium will bring together internationally-recognized scientists from academia, industry, regulatory agencies, and patient advocates to describe and discuss state-of-the art information about how systems biology is transforming cancer research. This symposium is directed towards scientists, scientists-in-training, physicians, physicians-in-training, students, and fellows interested in integrating large molecular data sets to generate information relevant to understanding the mechanism of cancer growth and ultimately diagnosing and treating it. For details, please click here. MARK YOUR CALENDARS– AFAR Conference on Cancer and AgingOctober 6-7 The American Federation on Aging Research (AFAR) is pleased to present Aging and Cancer: Two Sides of the Same Coin?, October 6-7 in New York. This two-day conference will explore fundamental aspects of aging and cancer processes and their interactions. Speakers will examine: genetic and epigenetic changes, environmental influences, and host factors such as oxidative stress and cell death. The evolutionary, cellular and molecular relationships among aging, tumor suppressor mechanisms and the development of cancer as well as the interactions of normal aging cells, stem cells and differences in the manifestation of cancer in young and old will also be discussed. Speakers will report on topics such as telomere biology; nuclear processes such as DNA damage, repair, replication, recombination and transcription; and relevant aspects of mitochondrial structure and function. The goal will be to elucidate genetic and epigenetic alterations that lead to aging and cancer phenotypes. For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESMesothelioma Applied Research Foundation |
NIH Bulletin – Notices and Funding Opportunities |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Green 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.green@uhhospitals.org |
|
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |